On days 7, 17, and 27 post-tumor inoculation, the Ad vaccines were administered to the lateral thighs of the mice with a total dose of Ad-CAIX or Ad-PD-L1 of 9 × 108 pfu per mouse (Fig. 1a). The gene discussed is CD274; the disease is neoplasm.